GSK2881078 (GSK-2881078) — Research Compounds Library | RetatrutideCompare

Selective androgen-receptor modulator developed by GSK for sarcopenia and chronic illness-related muscle wasting. Phase 2 trials reported lean-mass gains with ALT elevations limiting dose.